- 11-50 Employees
- Based in San Carlos, California
BioCardia, Inc., headquartered in San Carlos, California, is developing autologous and allogenic cell-based therapies to treat cardiovascular disease. CardiAMP™ and CardiALLO™ cell therapies are the Company’s biotherapeutic product candidates in clinical development. The Company has also developed a portfolio of approved enabling products that optimize delivery of its cell therapies.
Most Recent Annual Report
2019 Form 10K
Report Locked. BioCardia, Inc. has reached its limit for free report views.